Pathstone Holdings, LLC Bio N Tech Se Transaction History
Pathstone Holdings, LLC
- $21.9 Billion
- Q2 2024
A detailed history of Pathstone Holdings, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Pathstone Holdings, LLC holds 3,712 shares of BNTX stock, worth $422,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,712
Previous 4,100
9.46%
Holding current value
$422,945
Previous $378,000
21.16%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
327Shares Held
39.1MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$943 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$546 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$499 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$333 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$216 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...